Abstract:Abstract Background Mitral valve regurgitation (MVR) represents the second most frequent valvular heart disease. MV surgical repair is often the preferred treatment when MV anatomy is suitable. Purpose To characterize the population who underwent MV repair surgery and evaluate the outcomes of residual MVR, allcause mortality and functional classification. Methods Retrospective analysis of 262 patients (P) admitted between 2008 and 2017 for MV repair surgery. P who undergone simultaneous coronary artery bypass graft (CABG) surgery, atrial fibrillation (AF) surgery and tricuspid valve repair were also included. P with endocarditis, P who underwent simultaneous aortic valve replacement and P with rheumatic predominant MV stenosis were excluded, the remaining 204 P were analysed. Clinical and echocardiographic characteristics were evaluated in a mean follow-up of 30 months. Results 204 P, 67.2% male, mean age 62 + 14 years. The most frequent etiology was organic (80.4%), mostly of degenerative cause. Functional etiology was present in 19.6%, mostly ischemic (72.4%). 16.8% underwent simultaneous CABG, 12.3% tricuspid valve repair and 7.8% AF ablation. Hypertension was significantly associated with functional etiology (90% vs 72.8%, p = 0.022), as well as hypercholesterolemia (80% vs 48.2%, p < 0.001) and diabetes mellitus (32.5% vs 10.4%, p < 0.001). Baseline left ventricular ejection fraction (LVEF) was >50% in 78.4%, reduced (30-50%) 18.1% and poor (<30%) in 3.4%. Functional etiology was significantly associated with LVEF <50% (70% vs 9.1%, p < 0.001). 161P (78.9%) had MV prolapse: 120P (74.5%) posterior, 29P (18%) anterior and 7.4% (12P) of both leaflets. P2 was the most frequently involved scallop, in 92P (57.1%), followed by P3, in 41P (25.4%). There was MV chordae rupture in 94P (58.3%). Post-surgery echocardiography revealed that 93.8% had mild or no residual MVR. 30-day mortality rate was 0%. There was MVR recurrence with MV replacement surgery in 15P (7.5%), mean time 37.1 months. All-cause mortality was registered in 28P (13.7%), with a mean time of 43.7 months after MV surgery. Of the P without MVR recurrence or mortality, 111P (70%) were in NYHA class I, 41P (26%) in NYHA class II and 6P (4%) in NYHA class III. 6P were lost to follow-up. Upon echocardiographic revaluation there was no residual MVR in 53P (39%), mild MVR in 67P (49%) and moderate MVR in 16P (11.8%). Conclusion In P who underwent MV repair surgery, there was 7.5% recurrence rate with follow-up MV replacement surgery and an all-cause mortality of 13.7%. In a mean follow-up of 30 months, 70% of P were in NYHA I class and there was none or mild residual MVR in 88% of P.

The Effects of Mitral Valve Replacement with or Without Preservation of Subvalvular Apparatus on Postoperative Left Ventricular Function

Small Cavity of Left Ventricle Does Not Affect Short-term Outcome in Patients with Rheumatic Mitral Valve Stenosis Undergoing Mitral Valve Replacement.

Artificial Chordae Implantation vs Posterior Leaflet Preservation: A Comparison of Midterm Results After Mitral Valve Replacement

Surgical Management of Severe Ischaemic Mitral Regurgitation

Evaluating and Predicting the Outcomes of Mitral Valve Repair Using Echocardiogaphy

Analysis of Early Effect of Surgical Treatment in Patients with Coronary Heart Disease Complicated by Moderate-to-severe Ischemic Mitral Regurgitation

Mitral Valve Repair for Degenerative Mitral Regurgitation in Patients with Left Ventricular Systolic Dysfunction: Early and Mid-Term Outcomes

P1755 Clinical and echocardiographic outcomes of mitral valve repair surgery

Papillary muscle repositioning in valve replacement for left ventricular dysfunction: ischemic mitral regurgitation

Assessment of function on left atrial and biventricular in patients with rheumatic mitral stenosis before and after percutaneous mitral balloon valvuloplasty by real-time three-dimensional echocardiography

Clinical outcomes following surgical mitral valve repair or replacement in patients with rheumatic heart disease: a meta-analysis

Impact of preoperative cardiac function on the outcome of mitral valve repair

Preoperative risk factors of medium-term mitral valve repair outcome

Midterm Outcome of Valve Repair for Rheumatic Mitral Stenosis: 6-year Experience in a Single Mid-Volume Cardiac Center

Utility of Color Kinesis Technique to Evaluate Left Ventricular Regional Wall Motion after Different Methods of Mitral Valve Replacement

Early and long-term outcomes of mitral valve repair in degenerative mitral regurgitation

Clinical Study of the Efficacy of Different Types of Surgery in Elderly Patients with Mitral Valve Disease

[Early surgical outcomes of coronary heart disease with severe ischemic mitral regurgitation]

Surgical Repair for Non-ischemic Mitral Regurgitation with Left Ventricular Dysfunction

Abstract 16308: Comparison of Myocardial Mechanics Post Mitral Valve Repair With Leaflet Preservation vs. Leaflet Resection: A Sub-Analysis of the Randomized CAMRA CardioLink-2 Trial

Mid-term results of mitral valve replacement and repair: current clinical experience, technical aspects, and risk factor analysis